iRadimed (IRMD)
(Delayed Data from NSDQ)
$41.86 USD
+0.39 (0.94%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $41.69 -0.17 (-0.41%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 34% (86 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.57 | 9.99 |
Current Quarter Estimate | 0.34 | 3.93 | 60.00 |
Year Ago Quarter Estimate | 0.30 | 3.85 | 52.54 |
Next Quarter Estimate | 0.38 | 3.92 | 61.00 |
Next Year Estimate | 1.75 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 3.38 | 14.60 | 17.08 |
Next Year | 14.38 | 23.10 | 8.00 |
Last 5 Years | 25.30 | 10.00 | 8.10 |
Next 5 Years | NA | 14.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 28.02 | 29.13 |
Price/Book (MRQ) | 7.32 | 2.25 |
Price/Cash Flow (MRFY) | 29.12 | 15.17 |
Dividend Yield | 1.45% | 0.00% |
Net Profit Margin (TTM) | 26.22% | 7.88% |
Return on Equity (TTM) | 24.62% | 4.72% |
Debt to Equity (MRQ) | NA | 6.23 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.